RADIESSE INJECTABLE IMPLANT 8071M0K1

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional report with the FDA on 2020-03-24 for RADIESSE INJECTABLE IMPLANT 8071M0K1 manufactured by Merz North America, Inc..

Event Text Entries

[187694694] This case was assessed as reportable to the fda as the event, severe swelling, was deemed to meet the seriousness criteria of necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure. The device history record for radiesse lot number 100123538 was reviewed. A lot search was conducted on the reported lot and no similar events were noted. No non-conformances were noted that would contribute to this event.
Patient Sequence No: 1, Text Type: N, H10


[187694695] This spontaneous report was received from a us healthcare professional and concerns a female patient. She was injected with radiesse? Into the hands, on (b)(6) 2019. In (b)(6) 2019, since the treatment with radiesse? , the patient's left hand was swollen and had very unnatural appearance. The patient thought that too much product was injected. The outcome of the event was not reported. Follow-up information was received on 25-feb-2020: this case was upgraded to serious. The events pain with touch and mild erythema were added. The patients initials and date of birth were provided. She was (b)(6) years old. She was injected with a total of 2 ml of radiesse? (1 ml per hand). Batch number was reported as 100123538 (expiry date: 09/2022). The batch record review was received and the lot number for radiesse? Was confirmed as 100123538 (exp. 09/2022). A lot search in the global safety database was conducted. The patients medical history included breast cancer and thyroid cancer. The patients past medical history included a mastectomy and a lymphadenectomy to the left side. Concomitant medications were reported as none. On (b)(6) 2019, one day after the radiesse? Injection, the patient experienced swelling that was severe in nature. The patient also reported pain with touch and mild erythema. The patient was advised to keep the hand elevated above the heart, to perform compression, keep the hand moving to facilitate fluid removal, to perform icing and was prescribed over the counter pain medication. On (b)(6) 2019 the physician saw the patient and the events were fully resolved, reportedly within 2 - 3 weeks after the radiesse? Injection. No laboratory tests were performed. In the opinion of the reporter, treatment was necessary to prevent permanent damage, the events were not permanent and related to radiesse?.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3013840437-2020-00031
MDR Report Key9875545
Report SourceHEALTH PROFESSIONAL
Date Received2020-03-24
Date of Report2020-03-24
Date of Event2019-12-05
Date Mfgr Received2020-02-25
Device Manufacturer Date2019-09-24
Date Added to Maude2020-03-24
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactPRODUCT SAFETY
Manufacturer Street6501 SIX FORKS ROAD
Manufacturer CityRALEIGH, NC
Manufacturer CountryUS
Manufacturer Phone5828000
Manufacturer G1MERZ NORTH AMERICA, INC.
Manufacturer Street4133 COURTNEY STREET SUITE 10
Manufacturer CityFRANKSVILLE, WI
Manufacturer CountryUS
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameRADIESSE INJECTABLE IMPLANT
Generic NameIMPLANT, DERMAL, FOR AESTHETIC USE
Product CodeLMH
Date Received2020-03-24
Model Number8071M0K1
Catalog Number8071M0K1
Lot Number100123538
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerMERZ NORTH AMERICA, INC.
Manufacturer Address4133 COURTNEY STREET SUITE 10 FRANKSVILLE, WI US


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2020-03-24

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.